COST-EFFECTIVENESS OF COMPLYING WITH TREATMENT GUIDELINES IN SWEDEN

被引:0
|
作者
Jonsson, E. [1 ]
Hansson-Hedblom, A. [1 ]
Ljunggren, O. [2 ]
Akesson, K. [3 ]
Spangeus, A. [4 ]
Borgstrom, F. [1 ,5 ]
Kanis, J. A. [6 ,7 ]
机构
[1] Quantify Res, Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci Endocrinol & Mineral Metab, Uppsala, Sweden
[3] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Unit, Malmo, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[5] Karolinska Inst, Stockholm, Sweden
[6] Catholic Univ Australian, Melbourne, Vic, Australia
[7] Univ Sheffield, Sheffield, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P747
引用
收藏
页码:S440 / S440
页数:1
相关论文
共 50 条
  • [41] THE COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE COMPARED TO OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN SWEDEN
    Pudas, H.
    Hemels, M.
    Mehnert, A.
    Druais, S.
    Martin, M.
    VALUE IN HEALTH, 2011, 14 (07) : A560 - A561
  • [42] Cost-effectiveness of treating restless legs patients with pramipexole compared to no treatment in Sweden
    Lees, M.
    Roberts, G.
    Tabberer, M.
    Bjorkman, J.
    Ulfberg, J.
    Finnern, H.
    VALUE IN HEALTH, 2006, 9 (06) : A376 - A376
  • [43] COST-EFFECTIVENESS OF BOCEPREVIR IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN SWEDEN
    Chhatwal, J.
    Lundberg, J.
    Ferrante, S.
    El Khourhy, A. C.
    Oksanen, A.
    Elbasha, E. H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S386 - S387
  • [44] The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
    N. Zethraeus
    O. Ström
    F. Borgström
    J. A. Kanis
    B. Jönsson
    Osteoporosis International, 2008, 19 : 819 - 827
  • [45] EVALUATING THE COST-EFFECTIVENESS OF MULTICOMPONENT REHABILITATION GUIDELINES
    Mewes, J. C.
    Steuten, L. M. G.
    IJzerman, M. J.
    van Harten, W. H.
    VALUE IN HEALTH, 2013, 16 (03) : A30 - A30
  • [46] Cost-effectiveness of practice guidelines for smoking cessation
    不详
    ADDICTION, 1998, 93 (03) : 447 - 448
  • [47] Cost-effectiveness analysis of national clinical guidelines
    Van Os, N
    Niessen, LW
    Casparie, AF
    Van Hout, BA
    DIABETES, 1999, 48 : A416 - A416
  • [48] COST-EFFECTIVENESS GUIDELINES - THE EXPERIENCE OF AUSTRALIAN MANUFACTURERS
    GORHAM, P
    PHARMACOECONOMICS, 1995, 8 (05) : 369 - 373
  • [49] THE COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA IN SWEDEN
    Engstrom, A.
    VALUE IN HEALTH, 2014, 17 (07) : A639 - A639
  • [50] Cost-effectiveness of antidepressant treatment
    Head, L
    OKeane, V
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 88 - 88